Edition:
United Kingdom

Neos Therapeutics Inc (NEOS.OQ)

NEOS.OQ on NASDAQ Stock Exchange Global Market

7.15USD
23 May 2018
Change (% chg)

$0.05 (+0.70%)
Prev Close
$7.10
Open
$7.00
Day's High
$7.35
Day's Low
$7.00
Volume
52,072
Avg. Vol
68,161
52-wk High
$13.15
52-wk Low
$6.35

Chart for

About

Neos Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing, manufacturing and commercializing products utilizing its modified-release drug delivery technology platform. Its segment is engaged in the development, manufacturing and commercialization of pharmaceuticals. It has utilized its platform to... (more)

Overall

Beta: --
Market Cap(Mil.): $255.53
Shares Outstanding(Mil.): 28.08
Dividend: --
Yield (%): --

Financials

  NEOS.OQ Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -4.45 -- --
ROI: -84.78 14.84 14.38
ROE: -242.19 16.34 16.07

BRIEF-Neos Therapeutics Reiterates Confidence In Strategic Plan And Value Creation Opportunities

* NEOS THERAPEUTICS REITERATES CONFIDENCE IN STRATEGIC PLAN AND VALUE CREATION OPPORTUNITIES

20 Feb 2018

BRIEF-Jack Schuler Reports 8.1 Pct Passive Stake In Neos Therapeutics

* JACK SCHULER REPORTS 8.1 PERCENT PASSIVE STAKE IN NEOS THERAPEUTICS INC AS ON DECEMBER 31, 2017 - SEC FILING Source text: (http://bit.ly/2nOrQlw) Further company coverage:

08 Feb 2018

Competitors

  Price Chg
Eli Lilly And Co (LLY.N) $82.68 +0.46
Pfizer Inc. (PFE.N) $35.97 +0.25
Concordia International Corp (CXR.TO) $0.38 --
Novartis AG (NOVN.S) CHF76.16 -0.52
Shire PLC (SHP.L) 4,154.50 -64.00
Shire PLC (3159084.L) -- --

Earnings vs. Estimates